When you arrive in New Orleans, make your way to the registration area to receive your conference badge and essential materials, ensuring you're fully equipped for four days of engaging education sessions and valuable networking experiences.
Join us for a guided meditation and breathwork session at ACRP 2025. This session is brought to ACRP 2025 attendees by the ACRP Gulf States Chapter and will be facilitated by Marjorie Pokorny of Turtle Yoga, a local studio.
Space is limited–please RSVP.
About the faciliator:
Marjorie Pokorny is a 500RYT with certification in Hatha, Yin, Chair, and Restorative Yoga. After a lifetime of personal practice, she started teaching after retirement in order to share yoga practice with others. Turtle Yoga, located in New Orleans, opened in 2020 as a donation based, community focused studio. Marjorie is also a trained medicine woman, sound healer, crystal healer, reiki master, and spiritual mentor.
Join us for breakfast while connecting with 100+ leading-edge organizations and suppliers helping you get better results in clinical research.
Join us in the Expo Hall for networking with exhibitors and fellow clinical research professionals! Enjoy meals and connection opportunities throughout the day:
Breakfast: 8:00 – 9:00 AM
Networking & Exhibits: 8:00 AM – 2:00 PM
Lunch: 12:45 – 1:45 PM
Networking Reception: 4:30 – 6:00 PM
Visit the HCA Healthcare Headshot Studio during the times below for a complimentary professional headshot!
8:00 – 10:30 AM
12:00 – 2:00 PM
4:30 – 6:00 PM
Signature Series Session
Join Dr. David Burrow from FDA's Center for Drug Evaluation and Research as he explores operational strategies for implementing Quality by Design and the integration of Risk Based Quality Management Systems into routine trial design and conduct. Dr. Burrow will build on the key themes discussed in his 2024 Signature Series presentation titled, “Reimagining Clinical Research: The Transformation of Trial Design & Conduct” and bring his own unique perspectives to the next stage of reimagining clinical research and removing barriers to innovation. Take away practical approaches to mitigating obstacles, advancing the shared interests of human subject protection, generating high quality evidence of safety and effectiveness, and enabling action through strategies to manage fear - both as an organization and as an individual.
Objectives:
Discuss key themes of Quality by Design, Critical to Quality factors, and Risk Based Quality Management Systems.
Advance shared understanding of the CDER Center for Clinical Trial Innovation (C3TI) and other FDA drug development programs.
Provide strategies to advance innovation and enhance quality while also minimizing fear of regulatory oversight.
CEU: 1.00 ACRP
Speaker:
David Burrow, PharmD, JD, Director, Office of Scientific Investigations, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Related Blog Content:
The landscape of clinical trial design, conduct, and regulation continues to shift thanks to the rapid infusion of technology and an increased emphasis on inclusion and access. As a result, the U.S. Food and Drug Administration (FDA) and Congress are reevaluating their stances in a number of areas in order to further speed the path to healthcare innovation. However, these changes in policy can present operational challenges for sites and sponsors in the day-to-day management of trials and patient care. This session will run through the latest guidance changes and what they mean for sites and sponsors in 2025. Areas of focus will be the updated guidance on informed consent, diversity action plans, digital health technologies, decentralized clinical trials and Form FDA 1572 reform, use of real-world evidence, and changes to the FDA's Bioresearch Monitoring Program inspection processes. Additionally, the speakers will address the final ruling on taxing patient stipends, the Inflation Reduction Act, and the Food and Drug Omnibus Reform Act of 2022's mandate for innovation.
CEU: 1.00 ACRP
Speakers:
Catherine Gregor, MBA, CCRP, CCRC, Chief Clinical Trial Officer, Florence Healthcare
Sophia McLeod, Advocacy Advisor, Association of Clinical Research Organizations (ACRO)
Related Blog Content:
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
Study & Site Management Journey Sponsor
Community outreach remains the industry standard for patient recruitment in minoritized (and majority) communities. Defined as one-way communication, community outreach is often a transactional process that doesn’t typically leave room for bridging the gap between opportunity and community. While outreach may be necessary in some cases, we must begin to make a conscious shift toward engagement through true community partnerships for more equitable access and outcomes. This session is for those hoping to dive deep into community engagement planning and implementation for their organization. Attendees will come away with a new understanding of the pivotal role our communities play in shaping a more equitable and inclusive clinical trial landscape, and tools for deploying impactful and sustainable community engagement plans.
CEU: 1.00 ACRP
Speaker:
Ashley Moultrie, CCRP, Associate Director, Clinical Trial Diversity, Syneos Health
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
It seems as if everyone has their own way of designing case report forms (CRFs). For study coordinators, this can mean encountering new expectations (good, bad, or indifferent) from study to study, as well as the same things (truly necessary or not) across many studies. There's always a bit of copying and pasting happening, too, in the hope that lessons learned from prior studies will guide the development of future CRF content. But what if you could have a fail-proof process to ensure that the first draft of a CRF had 95% of the critical variables needed? Find out how using a statistics-driven approach can simplify CRF design. Cut out the noise by removing onerous and non-applicable checklist variables and focusing on only adding analyzable fields that make every single variable useful. During this talk, a research coordinator-turned-clinical research associate will also provide insight into how they contribute to the review process to ensure study flow at the site is taken into consideration.
CEU: 1.00 ACRP
Speakers:
Anna Rillo, BSN, RN, Study Director, Bright Research
Robin Solinsky, BS, VP, Technology & Innovation, Bright Research
Watch a Sneak Peek into the Session Content:
The future is here, and new technology available for investigational product (IP) management opens up a wide range of opportunities. In this session, we will provide an introduction to new IP temperature monitoring capabilities, cold chain innovation, digital automation, predictive analytics, and sustainable technologies that have the potential to enable enhanced quality and improve efficiency. We will also look at how new technologies at both the site and sponsor levels may support patient access to clinical trials and improve compliance with the tenets of ICH Good Clinical Practice.
CEU: 1.00 ACRP
Speakers:
Liza Hill, BS, ACRP-CP, ACRP-PM, Associate Director, Clinical Operations - Clinical Research Manager, Infectious Disease (US), Merck
Mary Williams, Associate Director, Clinical Operations, Merck
Watch a Sneak Peek into the Session Content:
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
Study & Site Management Journey Sponsor
Site-centric recruitment models powered by data and innovation are proving to be successful when two criteria are met--they reduce the burden on the site and they reach the patient closer to home. From "just-in-time" practices to decentralized clinical trials, this session will explore different recruitment models from the perspectives of experts who have successfully managed these approaches--both from the site and sponsor sides. Attendees will walk away with details and examples that they can apply to their efforts in clinical trial recruitment.
CEU: 1.00 ACRP
Speakers:
Noelle Gaskill, MBA, ACRP-CP, VP, GM of Time Network, Tempus
Karla Polk, Clinical Research Executive
Study & Site Management Journey Sponsor
In this session, we will examine barriers impeding effective decision-making and critical thinking in clinical research, including cognitive biases and information overload, and provide tips and scientifically based tools to help study team members navigate difficult decisions. Criteria for fostering a positive decision-making environment, emphasizing transparency and open communication, will also be examined. Attendees will engage in a thorough analysis of the deductive and inductive reasoning processes inherent to clinical research decision-making. By session's end, participants will emerge armed with empirically grounded strategies to navigate complexity, cultivate critical thinking, and drive impactful outcomes in their clinical research endeavors.
CEU: 1.00 ACRP
Speakers:
Ashley Bader, Clinical Research Nurse Manager, Tampa General Hospital
Alecia Sorrells, MS, BSN, RN, Clinical Research Nurse, Tampa General Hospital
Related Blog Content
Leadership & Professionalism Journey Sponsor
techXpo Session Sponsored by Phronetik and Microsoft
Discover how Phronetik leverages Microsoft’s cutting-edge technologies to revolutionize healthcare equity. In this engaging discussion, Phronetik’s Chief Growth Officer and Dr. Claude will outline collaborative advancements in AI-powered diagnostics, workforce diversity, and equitable access to research and healthcare services. The session will highlight how Microsoft’s tools and platforms are enabling Phronetik to drive meaningful health advancements in under-resourced communities. Attendees will gain insights into Microsoft’s commitment to fostering a resilient, equitable healthcare ecosystem through data-driven solutions, innovative AI integration, and actionable strategies for the future.
Speakers:
Damon House, Chief Growth Officer, Phronetik
Claude Louis-Charles, PhD, MBA, CISSP, Account Executive Director, Microsoft
In a post-pandemic landscape, learning, conducting, and implementing clinical trials significantly changed with the adoption of globally accepted decentralized methods. Variability across educational offerings may not assess learner competency to perform clinical research operational activities. In this panel, clinical investigators, a U.S. Food and Drug Administration representative, and educators will explore varied modalities for training investigators and consider avenues for comprehension in terms of learning on the job, through structured courses, by attending sponsor/contract research organization-conducted trainings, or by completing online modules--none of which may be sufficient in isolation. Fundamentals of online teaching and learning, coupled with adult learning methods and the industry's continued reliance on a "decentralized method of training," are pivotal to assess learner capability. In the absence of documented analysis and evaluation of the effectiveness of micro-credentials, presenters will discuss strengths/weaknesses, gaps, and challenges of the biopharmaceutical industry's reliance on the current modes of training and education of clinical research professionals.
CEU: 1.00 ACRP
Speakers:
David Burrow, PharmD, JD, Director, Office of Scientific Investigations, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Nadina Jose, MD, Assistant Professor, School of Health Profession, Rutgers, The State University of New Jersey
Anita Kablinger, MD, CPI, FAAP, FAPA, FACRP, FASCP, Professor, Academic Vice Chair and Director of Clinical Research, Department of Psychiatry and Behavioral Medicine, Virginia Tech Carilion School of Medicine, Virginia Tech Faculty of Health Sciences
Erika Stevens, MA, FACRP, Director, Research Experience, Rutgers
Watch a Sneak Peek into the Session Content:
Translational research is often driven by independent physician-investigators who want to bring medical innovations to the bedside. These pioneers take on the design, implementation, and compliance needs of their clinical trials, often without any formal training on research methodology. Similarly, lack of formal regulatory training creates challenges for busy investigators balancing their clinical and research responsibilities, and can put institutions at an increased risk of non-compliance, loss of reputation, and liability. Establishing an investigator-initiated research program (IIRP) can address the knowledge gap, foster translational research, and provide a support model that improves the quality of research, enhances reproducibility of results, and ensures compliance while protecting the rights of and maximizing the potential benefits for research participants. The session will focus on the importance of an IIRP regardless of research portfolio size, will deliver scalable steps for success. The example of a bottom-up approach will provide a framework for discussion and opportunity to share lessons learned.
CEU: 1.00 ACRP
Speakers:
Pamela Cooper, Manager, Investigator Initiated Research Program, Hackensack Meridian Health Inc
Elli Gourna Paleoudis, PhD, Director, Investigator Initiated Research Program and Support Services, Hackensack Meridian Health
Related Blog Content:
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
Understanding that site management organizations (SMOs) are essentially the bridge between the sponsor/contract research organization (CRO) and sites, we will demonstrate proven quality improvement practices used by SMOs to reduce start-up timelines. Roles discussed involve study activation, regulatory compliance, contracting and budgeting, clinical education, and clinical trial management system oversight. Participants will understand the function of each role and how the delineation of responsibilities improves site compliance, data quality, and sponsor/CRO satisfaction with a site's clinical trials. We will explore best practices using specific examples from real-world experiences, including technology use and templates covering communication, trial management, study and site specifics, etc.
CEU: 1.00 ACRP
Speakers:
Charita Braker, Manager, Clinical Research Education, HCA Healthcare Research Institute
Jessi Klindedinst, Manager, Regulatory Affairs, HCA Healthcare Research Institute
Related Blog Content:
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
An estimated 20% to 50% of trial protocols launched at sites will eventually close without a single enrolled participant, wasting considerable resources along the way. While not mandated, feasibility reviews are being utilized by many organizations to minimize the risk of opening studies that ultimately will fail. Stage-gate process, a framework described in industrial organization management, can help identify projects early that are likely not to succeed and stop them before extensive resources are invested, freeing those resources to support other projects more likely to succeed. The feasibility process should include review of a diverse array of resources--financial, human, and physical--as well as the ability to accrue needed participants. This presentation will discuss the stage-gate framework, provide tips on processes that can be used to implement a feasibility process, and offer metrics and data organizations can use to drive the analysis empirically.
CEU: 1.00 ACRP
Speaker:
Wendy Tate, PhD, MS, Product Strategy Senior Director, Advarra
Related Blog Content:
Watch a Sneak Peek of the Session Content:
Study & Site Management Journey Sponsor
Patient recruitment remains a significant challenge in our industry, often exacerbated by outdated U.S. Food and Drug Adinistration guidelines. Despite these constraints, there are ways to improve recruitment through better advertising practices. This panel brings together perspectives from sponsors/contract research organizations (CROs), institutional review boards (IRBs), and sites to discuss best practices within their organizations and how to form effective, mutually beneficial partnerships. We will focus on how sites and sponsors/CROs can implement winning strategies in patient recruitment advertising that also meet IRB review expectations. Each organization will offer actionable insights aimed at enhancing their processes to improve recruitment outcomes.
CEU: 1.00 ACRP
Speakers:
Meghan Joseph, Site Engagement, Patient Recruitment & Retention, Moderna
Jason Rush, BS, CIP, Senior Director, Regulatory, Advarra
Christine Senn, PhD, CCRC, CPI, FACRP, SVP, Site-Sponsor Innovation, Advarra
Kayra Velez, Senior Marketing Specialist, Centricity Research
Related Blog Content:
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
Recent discussions around diversity and inclusion have highlighted the limited participation of Americans in clinical research, with only 10 to 20 million out of 320 million involved. Many solutions, like decentralized clinical trials, focus on making participation easier for those already involved rather than reaching new participants. In my presentation, I will showcase initiatives and technologies aimed at recruiting those not yet participating in clinical studies, stressing that inspiration and education are key to growing the pool of engaged populations.
CEU: 1.00 ACRP
Speaker:
James Morton, PharmD, Adjunct Professor, UC San Diego Extended Studies
Watch a Sneak Peek into the Session Content:
Explore innovative ideas, research findings, and best practices in clinical research through our engaging poster presentations, displayed in the Expo Hall during open hours. Educational posters are visual summaries designed to present key information in a clear, concise, and compelling way. They allow researchers and professionals to share their work, spark discussions, and inspire new approaches to clinical research challenges.
Authors will be available for in-person Q&A at 1:30 PM on Friday and Saturday. Winners will be announced during the Saturday Networking Reception. We encourage attendees to stop by, view the posters, and engage with the presenters to deepen their understanding of the projects and connect with peers.
Posters:
Biospecimen Collection: The Cornerstone of Clinical Trials
Authors: Kay Murphy, Halley Losekamp
Building Research Capacity and Advancing Equity in Community Oncology Clinical Trials: A Pilot Training Program
Authors: Kimberly Demirhan, Sumanta Pal, Latha Shivakumar, Molly Kisiel, Elana Plotkin
Ghosting? More than a Dating Trend
Author: Leah Orozco
How to Be Your Own Internal Study Monitor
Author: Ann-Marie Jacobson
It’s Not you, It’s me. Where do we go now?
Author: Estela Staggs
Patient-Centered Consent: Bridging Trust in Clinical Research
Authors: Megan Rodgers, Andrea Gutierrez
Pediatric Site Response to Rapid Implementation of Decentralized Clinical Trials (DCTs)
Author: Abigail Kietzman
Site-Enabled Decentralized Clinical Trial Model for Rare Diseases
Authors: Alpa Khushalani, Amy Chestnut
Understanding the Role of CROs and Sponsors During the Feasibility Process to Increase Enrollment for Racial and Ethnic Minorities in Clinical Trials
Author: Jalen Denson
Signature Series Session
Meaningful change can come from the top down and the ground up—but in clinical research, valuable perspectives from seasoned professionals in the field have been silent for too long. This session builds on an NIH survey that was first examined at ACRP 2024 and then expanded upon in a pioneering national survey by ACRP and Continuum Clinical in December 2024 with the goal of understanding how to improve clinical trials from those who implement and manage trials.
Through the lens of transformation, this survey goes beyond the barriers that are typically captured to explore real-world actionable insights for clinical trial implementation, our current state, where do we want to go from here, and the changes needed to reach an ideal future state.
Come hear wisdom gathered from clinical research professionals just like yourself--and share your voice in this lively discussion! Our speakers will share the survey insights and propose practical, solutions-based approaches to overcome the reported barriers. All ACRP 2025 registrants will receive exclusive access to a pre-read document before the conference to help set the stage for the discussion in New Orleans.
Join us for this engaging session to discover actionable solutions to the issues that hinder successful clinical trials. Your colleagues (and hopefully, you!) have spoken, so don't miss out!
CEU: 1.00 ACRP
Speakers:
Jeri Burr, MS, RN, PED-BC, CCRC, FACRP, Program Director, University of Utah
David Burrow, PharmD, JD, Director, Office of Scientific Investigations, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Paul Ivsin, Executive Vice President, Trial Engagement Service, Continuum Clinical
Edwina McNeill-Simaan, EdD, MSHS, CCRC, CCRP, Program Director, Vanderbilt University Medical Center
Nancy Sacco, PhD, VP Head of Clinical and Site Development Operations, SiteBridge Research Inc
Pamela Tenaerts, MD, Chief Scientific Officer, Medable
Leadership & Professionalism Journey Sponsor
In this session, we will dive into the history of women leadership and discuss barriers women face in clinical research leadership positions. What is the leadership landscape in clinical research and how can you be an effective leader in it? Let’s create a Blank Space and level the playing field by breaking those barriers. How will we do this? By embracing a journey of change, being fearless, and mastering the strategies necessary for overcoming barriers as a female leader and achieving success.
CEU: 1.00 ACRP
Speaker:
Jessica Fritter, DHSc, MACPR, ACRP-CP, Associate Clinical Professor, The Ohio State University
Related Blog Content:
Watch a Sneak Peek into the Session Content:
Leadership & Professionalism Journey Sponsor
The session will focus on various types of protocol designs and changes, with an emphasis on adaptive designs. We will review the FDA guidance on “Adaptive Designs for Clinical Trials of Drugs and Biologics.” Taking a deeper dive into unplanned design changes and regulatory considerations, we will engage in one of the oldest thought experiments in Western philosophy, the Ship of Theseus, to address an ambiguity in clinical trial design. Here, we will consider alternative ways protocols are commonly modified, and whether those changes could be considered an entirely new clinical trial, rather than a modification. This session will also provide an educational background in trial design for professionals who haven't had as much exposure to the topic as they wish, and will include a detailed review of sections of ICH E8(R1) and ICH E6(R2), where they relate to trial design.
CEU: 1.00 ACRP
Speaker:
Amanda Egan, Associate Clinical Research Associate, Merck
Watch a Sneak Peek into the Session Content:
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
In this session, an expert panel with members representing a top 10 industry sponsor; a research and policy center; an independent nonprofit organization; and a pharmaceutical business intelligence provider will share actionable insights on expanding the scope of diversity in clinical trials. The panelists will elaborate on the section of the new U.S. Food and Drug Administration (FDA) diversity plan guidance stating that "FDA advises sponsors to seek diversity in clinical trial enrollment beyond populations defined by race and ethnicity, including other underrepresented populations defined by demographics.”
CEU: 1.00 ACRP
Speakers:
Sylvia Baedorf Kassis, MPH, Program Director, Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard
Behtash Bahador (he/him), Director of Health Literacy, Center For Info & Study on Clinical Research Participation (CISCRP)
Fenwick Eckhardt, Head of Diversity Strategy, Citeline
Meghan McKenzie, MA, Director of Health Equity and Clinical Research, Genentech's Chief Diversity Office
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
Research team retention and engagement heavily impacts enrollment and program performance. Join Michelle Rowe from HCA Healthcare Research Institute, as she leads a discussion on talent retention, onboarding, and colleague development. During the panel discussion attendees will hear from HCA Healthcare leaders from Site Operations, Quality & Compliance, Strategic Projects, and Human Resources on the important challenges facing programs today and practical and effective pathways forward. Leave the discussion with knowledge on approaches to onboarding across over 43 sites of care with a core belief that HCA Healthcare's greatest strength is its talent. Discover practical strategies to standardize talent retention by making actionable ownership of colleague development an intrinsic part of the culture of your program.
This session does not provide ACRP Contact Hours.
Speakers:
Andrea Berkovsky, Director of HR, HCA Healthcare Research Institute
Lauren Horton, PhD, Director of Research, North Texas Division, HCA Healthcare Research Institute
Sybil Hyatt, MBA, RN, AVP Site Operations, HCA Healthcare Research Institute
Michelle Rowe, RN, VP, Research Institute, HCA Healthcare Research Institute
Robbin Seago, AVP Research Ethics & Compliance, HCA Healthcare Research Institute
This session is sponsored by
The U.S. Food and Drug Administration's (FDA’s) recent guidance for institutional review boards on informed consent was the first update to the old “information sheets” on the topic in nearly 20 years. The Office for Human Research Protections beat FDA to the punch with new consent form requirements, but does the latest guidance mean there is a new “reasonable person” in the room? In this session, we will break down the new FDA guidance and what it means for accredited Human Research Protection Programs. Some organizations may not need to make any extensive changes, but there are differences between the FDA guidance and the expectations of the Common Rule concerning informed consent that must be considered.
CEU: 1.00 ACRP
Speaker:
James Riddle, MCSE, CIP, CPIA, CRQM, SVP Global Review Operations, Advarra
Related Blog Content:
Watch a Sneak Peek into the Session Content:
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
Leveraging electronic tools is essential for maintaining inspection readiness in today's regulatory landscape. Paper-based methods are cumbersome and time-consuming, and they create logistical challenges in record keeping. In contrast, technology offers centralized record keeping, and electronic file storage is now both cost-effective and user-friendly. This shift is underscored by updated guidelines such as ICH E6(R3), which promotes media neutrality, flexibility, innovation, proactive quality, and robust data governance. Additionally, remote regulatory assessments, which were proven effective during the pandemic, enhance efficiency, flexibility, and global reach while reducing travel and disruption. Despite these advancements, recent feedback from regulators indicates a regression in the adoption of these technological tools. It is time for sponsors to embrace risk proportionality, which is supported by regulatory authorities, to maintain inspection readiness.
CEU: 1.00 ACRP
Speaker:
Marc Wartenberger, CQA, CTFL, Senior Director, Security, Corporate QA & Compliance, CRIO
Related Resource:
The new ACRP Guidelines and Regulations Resource Center has the most relevant and up-to-date resources for all professionals whose roles involve conducting and leading clinical research. ACRP will post updates and links to content impacted by the changes to the ICH E6(R3) Good Clinical Practice Guidelines.
Payment for services in the healthcare industry is handled unlike the payment process for any other business. Learn the different models by which investigators can be compensated; the basics of the Anti-Kickback Statute, the False Claims Act, and the Stark Law; how they govern investigator payment; and the average per-patient investigator compensation by trial type. The speaker will share one hospital’s experience with successfully compensating physicians based on the various types of medical groups and hospital physicians they contract with. In this session, attendees can be prepared to learn about managing investigator payments; creating compensation that is fair, motivational, affordable, practical, legal, and agreeable; and motivating investigators without incentivizing them to perform clinical trials.
CEU: 1.00 ACRP
Speaker:
Suzanne Rose, MS, PhD, Executive Director of Research, Stamford Hospital
Watch a Sneak Peek into the Session Content:
Study & Site Management Journey Sponsor
